Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Lentine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ritedose to Manufacture Tenpoint's Presbyopia Eye Drops
    Ritedose to Manufacture Tenpoint's Presbyopia Eye Drops

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270117/0/en/Ritedose-Announces-Manufacturing-for-Tenpoint-Therapeutics-Presbyopia-Eye-Drop.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Tenpoint YUVEZZI Launches Nationwide US
    Tenpoint YUVEZZI Launches Nationwide US

    30 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260330960621/en/YUVEZZI-from-Tenpoint-Therapeutics-Ltd.-Is-Now-Available-Nationwide-Across-the-United-States

    BUSINESSWIRE
    30 Mar 2026
    Share Share
    Vis’ Yuvezzi Receives Approval in US
    Vis’ Yuvezzi Receives Approval in US

    28 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220142

    FDA
    28 Jan 2026
    Share Share
    Tenpoint-Therapeutics-Receives US FDA Approval YUVEZZI
    Tenpoint-Therapeutics-Receives US FDA Approval YUVEZZI

    28 Jan 2026

    // PRESS RELEASE

    https://tenpointtherapeutics.com/wp-content/uploads/2026/01/Tenpoint-Therapeutics-Receives-US-FDA-Approval-YUVEZZI_Final_1_28_26.pdf

    PRESS RELEASE
    28 Jan 2026
    Share Share
    Visus & Zhaoke Enter Excl. Licensing Agreement for BRIMOCHOL PF, Carbachol PF
    Visus & Zhaoke Enter Excl. Licensing Agreement for BRIMOCHOL PF, Carbachol PF

    11 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220511005170/en

    BUSINESSWIRE
    11 May 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.